HK1102373A1 - Pseudopeptides growth hormone secretagogues - Google Patents

Pseudopeptides growth hormone secretagogues

Info

Publication number
HK1102373A1
HK1102373A1 HK07109314A HK07109314A HK1102373A1 HK 1102373 A1 HK1102373 A1 HK 1102373A1 HK 07109314 A HK07109314 A HK 07109314A HK 07109314 A HK07109314 A HK 07109314A HK 1102373 A1 HK1102373 A1 HK 1102373A1
Authority
HK
Hong Kong
Prior art keywords
growth hormone
pseudopeptides
release
growth
hormone secretagogues
Prior art date
Application number
HK07109314A
Other languages
English (en)
Inventor
Deghenghi Romano
Original Assignee
Mediolanum Framaceutici S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/835,563 external-priority patent/US7034050B2/en
Application filed by Mediolanum Framaceutici S P A filed Critical Mediolanum Framaceutici S P A
Publication of HK1102373A1 publication Critical patent/HK1102373A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK07109314A 2004-04-28 2007-08-27 Pseudopeptides growth hormone secretagogues HK1102373A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/835,563 US7034050B2 (en) 2004-04-28 2004-04-28 Pseudopeptides growth hormone secretagogues
US64279305P 2005-01-11 2005-01-11
PCT/EP2005/004273 WO2005105828A1 (en) 2004-04-28 2005-04-21 Pseudopeptides growth hormone secretagogues

Publications (1)

Publication Number Publication Date
HK1102373A1 true HK1102373A1 (en) 2007-11-16

Family

ID=34967415

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07109314A HK1102373A1 (en) 2004-04-28 2007-08-27 Pseudopeptides growth hormone secretagogues

Country Status (11)

Country Link
EP (1) EP1756142B1 (es)
JP (1) JP2008501641A (es)
AT (1) ATE399791T1 (es)
CA (1) CA2564613A1 (es)
CY (1) CY1108304T1 (es)
DE (1) DE602005007895D1 (es)
ES (1) ES2309756T3 (es)
HK (1) HK1102373A1 (es)
PL (1) PL1756142T3 (es)
PT (1) PT1756142E (es)
WO (1) WO2005105828A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277113B1 (it) * 1995-12-20 1997-11-04 Romano Deghenghi Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita

Also Published As

Publication number Publication date
ES2309756T3 (es) 2008-12-16
CY1108304T1 (el) 2014-02-12
WO2005105828A1 (en) 2005-11-10
PT1756142E (pt) 2008-09-29
JP2008501641A (ja) 2008-01-24
DE602005007895D1 (de) 2008-08-14
PL1756142T3 (pl) 2008-12-31
EP1756142B1 (en) 2008-07-02
ATE399791T1 (de) 2008-07-15
CA2564613A1 (en) 2005-11-10
EP1756142A1 (en) 2007-02-28

Similar Documents

Publication Publication Date Title
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
ATE365045T1 (de) Vermehrung des weich- sowie des knochengewebes anhand von aus muskeln stammenden vorläuferzellen,sowie damit verbundene zusammensetzungen und behandlungsformen
IL188475A0 (en) Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors
AR078304A1 (es) Agonistas receptores de oxitocina
MX2010004682A (es) Metodo de supresion de hormonas en humanos.
WO2007014258A3 (en) Growth hormone secretagogues
AU2003248888A1 (en) Peptide composition for treatment of sexual dysfunction
WO2009052489A3 (en) Novel inhibitors of mammalian tight junction opening
TW200637561A (en) Antitumor agent
ATE537249T1 (de) Wiedergewinnung von gewebefunktion nach verabreichung von b-zellen an verletztes gewebe
MXPA04011835A (es) Tratamiento de combinacion para la depresion y ansiedad.
TW200612962A (en) Estriol and estetrol prodrugs
MX2007005525A (es) Tratamiento terapeutico de resorcion ose acelerada.
HK1102373A1 (en) Pseudopeptides growth hormone secretagogues
GB0203419D0 (en) Peptide
GB0203420D0 (en) Peptide
DE60318716D1 (de) Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
EP1730174A4 (en) PEPTIDE CARRIER FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS
Du et al. Modulation of orphanin FQ or electroacupuncture (EA) on immune function of traumatic rats
HK1092162A1 (en) Biologically active peptides comprising isoleucyl-valyl-threonyl- asparaginyl-threonyl-threonine (ivtntt)
MX2009002985A (es) Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (tsh).
AU2003220441A1 (en) Dipeptidic growth hormone secretagogues
WO2005062874A3 (en) Compounds and compositions for delivering active agents
RS20050738A (en) Pharmaceutical combination for the treatment of s pasticity and/or pain

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120421